Loading
Latest filing published 11 May 2022 for JBG SMITH Properties, €23k.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Alan S. Forman, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Stemline Therapeutics Inc and JBG SMITH Properties. The record holds 10 filings, for trades running from 23 June 2015 to 10 May 2022.
The open-market record is one-sided, with 5 purchases worth €134k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 4 share grants. In 2022 alone, the filings show 3 purchases and no sales.
Half of the purchases are above €23k and half below. Across 5 purchases, this insider has always bought alone, with no colleague buying within 30 days. Ninety days after publication, 3 purchases show a median change of -1.2%, with the price up in 0% of them. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 11 May 2022, reports an open-market purchase of €23k in JBG SMITH Properties. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations